SCHEMBL6529499

SCHEMBL6529499

CC1(c2ccccc2)CCN(Cc2cccc(Oc3ccccc3)c2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.65
KDM4E B2RXH2 3/20 0.65
TDP1 Q9NUW8 1/20 0.65
HPGD P15428 1/20 0.61
HTT P42858 1/20 0.61
LMNA P02545 1/20 0.57
GAA P10253 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
CCR8 P51685 8/20 0.56
KCNH2 Q12809 4/20 0.56
TRPV6 Q9H1D0 1/20 0.56
SIGMAR1 Q99720 2/20 0.55
OPRM1 P35372 2/20 0.55
OPRK1 P41145 2/20 0.55
CACNA1F O60840 1/20 0.55
CHRM2 P08172 1/20 0.55
ADRB1 P08588 1/20 0.55
DRD2 P14416 1/20 0.55
SLC6A2 P23975 1/20 0.55
ADRA1D P25100 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7129026 0.84 OPRL1 (0.69) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL3252230 0.83 OPRL1 (0.65) ALDH1A1LMNAGAASIGMAR1OPRM1
Hydrochloric Acid SCHEMBL6160179 0.81 POLB (0.66) ALDH1A1LMNAGAASIGMAR1OPRM1
SCHEMBL27550808 0.81 OPRL1 (0.63) ALDH1A1LMNAGAASIGMAR1OPRM1
SCHEMBL6528764 0.81 OPRM1 (0.71) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL7126258 0.81 KDM4E (0.60) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL6499571 0.80 ALDH1A1 (0.75) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL18177893 0.79 ALDH1A1 (0.78) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL6496864 0.79 ALDH1A1 (0.73) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL13743319 0.78 ALDH1A1 (0.70) ALDH1A1KDM4ETDP1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor CCR8, CCL11, CCR5 ALDH1A1 1071/4885KDM4E 4617/4885TDP1 3425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.